Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?
Acute Myeloid Leukemia
- AML comprises several distinct entities that are genetically and epigenetically heterogeneous
- Cytogenetic and molecular heterogeneity is clinically relevant and has been used for risk-stratification, treatment selection and treatment guidance
- However, this approach lacks of the necessary accuracy.
Presentation: 54 minutes
Recommended CitationMarcucci, MD, Guido, "Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?" (2014). Kimmel Cancer Center, Presentations and Grand Rounds. Paper 17.